Legislating Hemp As Dietary Ingredient: Wrapping US Market In A Bow, Or Tying DSHEA In Knots?
Executive Summary
House legislation to exempt hemp-derived cannabinoids from FDA rule that an “article” previously studied or approved for use as drugs is not allowed for use in dietary supplements either resolves a conundrum or raises additional questions for the agency and the industry.
You may also be interested in...
US FDA Continues Cannabinoid Analysis Required In FY2021 Budget
FDA is testing cannabidiol and other cannabinoids for whether labeled amounts match what’s in a product, says CFSAN Deputy Director Doug Stearn. The work is supported with $5m provided in the agency’s FY21 appropriation.
US House Co-signs Banking For Hemp Industry
House passes “SAFE Banking” Act sponsored by Rep. Ed Perlmutter to allow cannabis- and hemp-related businesses in states with some form of legalized marijuana to access financial services by creating protections for those institutions. Sen. Jeff Merkley introduced the same legislation in March.
Pocono Organics Sprouts Full-Spectrum Cannabinoids Line Grown In Regenerative Farming
Pennsylvania firm's CBD line is only one with the Rodale Institute’s logo to indicate the high standards and responsible farming practices used to make the items. The line includes artisanal, small-batch tinctures, creams, salve sticks, lip balms, massage oil and bath bombs.